Clinical Study
Newborn Screening for Sickle Cell Disease: Technical and Legal Aspects of a German Pilot Study with 38,220 Participants
Table 1
Detailed information on screening-positive babies.
| | Patient number (ethnical origin) | Screening patterns HPLC/CE | Molecular genetic result |
| | # 1 (West African) | FSa/FS | SCD-S/S | | # 2 (West African) | F5SaB/FS | SCD-S/S | | # 3 (Middle East) | FSa5B/FS | SCD-S/β 0 thalassemia | | # 4 (West African) | FaCS/FSC | SCD-S/C | | # 5 (Middle East) | F4SA/FS | SCD-S/S | | # 6 (West African) | FSCa/FSC | SCD-S/C | | # 7 (Middle East) | FSa5/FS | SCD-S/S | | # 8 (West African) | FSaB/FS | SCD-S/S | | # 9 (West African) | FS4a/FS | SCD-S/S | | # 10 (West African) | FS5aB/FS | SCD-S/S | | # 11 (West African) | FCSa/FSC | SCD-S/C | | # 12 (West African) | FSa2B/FS | SCD-S/S | | # 13 (West African) | FSa2B/FS | SCD-S/S | | # 14 (West African) | FCS1/FSC | SCD-S/C |
|
|
